Chemo beads plus artery infusion for advanced lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new way to treat advanced non-small cell lung cancer by combining two targeted interventional procedures: one puts tiny beads with chemo directly into the tumor (DEB-BACE), and the other uses an artery to deliver treatment (BAI). The goal is to shrink the tumor and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with non-small cell lung cancer (NSCLC) that is stage III or IV.
- You are newly diagnosed, or your first treatment did not work, or you cannot have surgery, chemo, or radiation.
- You are generally able to care for yourself (score 2 or less on a standard scale).
- You have not had certain interventional treatments (like iodine seeds, ablation, or TACE) before.
- You do not have other cancers, uncontrolled spread to liver/brain/bones, or serious health issues like kidney or liver failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at the safety and effectiveness of a treatment called DEB-BACE, which delivers chemotherapy directly into lung tumors using tiny beads. If you have already had this treatment, your records may help researchers learn more about its benefits and risks.
This trial tests a treatment called bronchial artery chemoembolization (BACE) combined with drug therapy for advanced non-small cell lung cancer. BACE delivers chemotherapy directly to the tumor through the blood vessel that feeds it, which may help control the cancer when standard treatments have stopped working.
This trial is testing a new use of a procedure called BAI-BACE (injecting drugs or blocking blood flow through the bronchial artery) for people with advanced lung squamous cell carcinoma that hasn't responded to prior treatments. The goal is to see if this treatment can help control the cancer when it's still only in the chest.
This trial compares a combination of anti-angiogenics (bevacizumab) plus chemotherapy (paclitaxel and carboplatin) against Avastin-based treatment in people with advanced non-small cell lung cancer. It aims to find out whether the study treatment is safer and works better for shrinking tumors and improving outcomes.
This trial tests a combination of a new drug (D-BACE), chemotherapy, and carlizumab for people with a certain type and stage of lung cancer that can be removed with surgery. It aims to see if this combination helps shrink tumors and improves outcomes.
This trial compares two treatments for colorectal cancer that has spread to the liver: using tiny beads that deliver chemo directly to the tumor plus a liver infusion, versus the liver infusion alone. It aims to see which approach is safer and more effective.
Hear when a new Carcinoma, Non-Small-Cell Lung trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.